<--- Back to Details
First PageDocument Content
Science / Resistance Database Initiative / Antiretroviral drug / HIV / Infectious disease / AIDS / Methadone / Zidovudine / National Institute of Allergy and Infectious Diseases / HIV/AIDS / Medicine / Health
Date: 2012-09-28 07:38:22
Science
Resistance Database Initiative
Antiretroviral drug
HIV
Infectious disease
AIDS
Methadone
Zidovudine
National Institute of Allergy and Infectious Diseases
HIV/AIDS
Medicine
Health

Poster: 119 International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies 5-9 June 2012; Sitges, Spain A global non-profit initiative against HIV drug resistance

Add to Reading List

Source URL: www.hivrdi.org

Download Document from Source Website

File Size: 620,43 KB

Share Document on Facebook

Similar Documents

PRESS RELEASE Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF BETHLEHEM, PA- October 10, 2012 ‐ Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of a

PRESS RELEASE Particle Sciences to Develop Antiretroviral Formulations as part of MOTIF BETHLEHEM, PA- October 10, 2012 ‐ Particle Sciences, a leading drug delivery CRO, has been selected to be the formulation arm of a

DocID: 1m6of - View Document

Microsoft Word - Biographie de JF Delfraissy BIS.doc

Microsoft Word - Biographie de JF Delfraissy BIS.doc

DocID: 1gw3d - View Document

Surveillance and outbreak reports  Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S

Surveillance and outbreak reports Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy C Semaille ()1, Y Le S

DocID: 1gvMD - View Document

Questioning the HIV-AIDS hypothesis: 30 years of dissent

Questioning the HIV-AIDS hypothesis: 30 years of dissent

DocID: 1gtoc - View Document

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use FULYZAQ safely and effectively. See full prescribing information for FULYZAQ. FULYZAQ ® (crofelemer) delayed-releas

DocID: 1gtlL - View Document